Small regulatory RNAs, including miRNAs, are instrumental in regulating human health and have been associated with a wide range of different diseases. Oligonucleotide therapies, including antisense oligonucleotides (ASOs) and RNA interference (RNAi), represent a unique class of gene therapies that have the potential to provide highly focused, long-lasting therapeutic effects by utilizing similar cellular processes.

Advanced Cell Diagnostics miRNAscope ISH technology has become the gold standard for identifying the cellular localization of endogenous miRNAs and measuring delivery efficiency of therapeutic oligonucleotides in preclinical animal models. Combining proprietary RNAscope and miRNAscope ISH technologies, we are now introducing the RNAscope Plus smRNA-RNA LS assay which is designed as an automated assay on the Leica Biosystems' BOND RX Research Advanced Staining System.  It is a valuable new tool to quantify changes in gene expression and cellular function in response to the introduction of regulatory RNAs, essential for optimization of therapeutic efficacy and safety.

Key Features:

• Unlock the potential to detect 1 small RNA along with up to 3 mRNA targets on the Leica Biosystems' BOND RX automated staining system
• Visualize antisense oligonucleotides (ASOs), microRNAs (miRNAs), small interfering RNAs (siRNAs), and other smaller RNAs that are 17-50 nt in length along with up to 3 mRNA targets
• Visualize gene regulation with morphological context
• Validate miRNA biomarkers in intact tissues
• Assess small RNA therapeutic delivery and biodistribution
• Add a visual dimension to interrogate heterogeneous tissues and evaluate therapeutic efficacy.
• Combined ACD patented signal amplification system and the Tyramide Signal Amplification (TSA™) technology

Brochure

 

Introducing the RNAscope Plus small RNA-RNA Fluorescent Assay

Download Brochure

 

Flyer

Biodistribution, safety and efficacy assessment of small RNAs with the new RNAscopeTM Plus small RNA-RNA co-detection Assay

Download Flyer

 

Technology Overview:

RNAscope Plus smRNA-RNA LS assay allows simultaneous detection of 1 smRNA and up to 3 RNA targets within a single sample using up to four target probes and the nuclei can be counterstained and visualized using DAPI fluorescent dye. The four target probes, each designed in a different probe channel—S1 for smRNA, and C2, C3, or C4 for RNA targets. The assay is compatible with formalin-fixed, paraffin-embedded (FFPE) and fresh frozen (FF) tissue.

The key technological advantage of this assay is the significant signal boost with simultaneous background noise suppression which is due to advances in ACD’s patented signal amplification technology combined with Tyramide Signal Amplification (TSA™) technology.

Guidelines for Microscope Channel Selection:

RNAscope Plus smRNA-RNA LS assay supports interrogation of up to 4 target probes. The assay uses four target probes with each probe designed in a different channel – the S1 channel for smRNA and C2, C3 and/or C4 channels for other RNA targets. The nuclei can be counterstained and visualized using DAPI fluorescent dye. For viewing of 4 plex assay, a multiplexed biomarker imaging system is required, such as Nuance FX Multiplex Biomarker Imaging System, Vectra 3.0 Automated Quantitative Pathology Imaging System or Mantra Quantitative Pathology Workstation Akoya Biosciences.

Fluorophore options depend on the imaging systems available. Two color combination examples are shown in the following table. Multispectral un-mixing capability are required for certain options.

What to order
Visualization requires a multispectral fluorescent imaging system (e.g. Nuance FX Multiplex Biomarker Imaging System)

Order the following components from ACD:

Fluorophores required to perform RNAscope smRNA-RNA LS Fluorescent Assay

Required materials and equipment from Leica BOND RX
The RNAscope smRNA-RNA LS Fluorescent Assay requires specific materials and equipment available only from Leica Biosystems.